Ishami Mpuzamahanga

Ku itariki ya 20 Kanama 2025, ikigo cy’ubuvuzi cya Abbisko cyatangaje ko ikigo gishinzwe gusuzuma imiti (CDE) cy’ikigo cy’igihugu gishinzwe imiti y’ubuvuzi cy’Ubushinwa (NlPA) cyemeye ubusabe bwa lND bwo gukoresha umuti w’ubushakashatsi wa Abbisko wo mu kanwa witwa ABSK043, hamwe na Shanghai Alist Pharmaceuticals KRAS ...Soma byinshi»

Vuba aha, inyigo ya Antengene's Phase I/II CLINCH kuri ATG-022 (CLDN18.2 antibody-drug conjugate), umurwayi ugeze mu zabukuru ufite kanseri y'igifu ikomeye, wakomeje kuvura indwara zitandukanye, ubudahangarwa bw'umubiri ndetse n'ubuvuzi bugamije abantu benshi nubwo habayeho kugabanuka k'imitsi myinshi, yagize uruhare runini mu gusubiza neza (CR).Soma byinshi»

Ku ya 13 Kanama 2025, urubuga rwemewe rw’Inama Mpuzamahanga ku Kanseri y’Ibihaha yo mu 2025 (WCLC) rwashyize ahagaragara incamake z’ubushakashatsi bwatoranyijwe mu nama y’uyu mwaka, Imwe mu ngingo z’ingenzi harimo incamake nshya y’igerageza rya mbere rya HLX43, Henlius’ PD-L1 ADC. A...Soma byinshi»

Ku ya 7 Kanama, Ikigo Gishinzwe Isuzuma ry’Imiti (CDE) cy’Ikigo cy’Igihugu Gishinzwe Ibikoresho by’Ubuvuzi (NMPA) cyatangaje ko hatanzwe inshinge za PA3-17 kugira ngo zishyirwe mu cyiciro cy’ubuvuzi bugezweho, bugenewe kuvura abarwayi bakuru bafite lymphatic T-cell acute lymph yasubiwemo/isubira inyuma...Soma byinshi»

Ku ya 11 Kanama, Ikigo Gishinzwe Isuzuma ry’Imiti (CDE) cy’Ikigo cy’Igihugu Gishinzwe Ibikoresho by’Ubuvuzi (NMPA) cyagaragaje ko ubusabe bwa InxMed bwo gukoresha ibinini bya IN10018 bwatanzwe kugira ngo buvurwe neza, bugenewe guhuzwa na D-1553 kugira ngo buvure KRA igezweho cyangwa ikwirakwira mu gace runaka...Soma byinshi»

Bwana X ni umurwayi uri mu kigero cy'imyaka 40 wafashwe n'indwara ya melanoma ya acral. Nyuma yo kubagwa bikomeye nyuma yo kuvurwa mu 2015, yakomeje kugira ubuzima bwiza mu gihe cy'imyaka icyenda. Ikibabaje ni uko hashize umwaka umwe, indwara ye yongeye kugaruka mu bihaha byombi. Nubwo yafashwe n'indwara ya inguinal na hipped...Soma byinshi»

Ku ya 31 Nyakanga, AstraZeneca na Merck & Co. batangaje ku bufatanye ko umuti wabo wa Lynparza ugabanya PARP, hamwe na Abiraterone na prednisolone, wemejwe mu Bushinwa mu kuvura abarwayi bakuru barwaye kanseri ya prostate irwanya castration (mCRPC) bafite germline cyangwa se ...Soma byinshi»

Ku ya 31 Nyakanga 2025, Ikigo gishinzwe imiti (ImmuneOnco Biopharmaceuticals) cyatangaje amakuru y’ibanze ku mutekano n’ubushobozi bw’inyigo yakozwe mu cyiciro cya kabiri cya IMM2510 ivanze na chimiotherapie ku barwayi bari ku murongo wa mbere barwaye kanseri y’ibihaha itari iy’uturemangingo duto (NSCLC) yakozwe mu Bushinwa. Guhera ku ya 1 Nyakanga 2025,...Soma byinshi»

Ku ya 30 Nyakanga, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi (NMPA) cyemeje ku mugaragaro kwamamaza HICARA mu kuvura abarwayi bakuru bafite lymphoma ya B-cell lymphoma ikomeye cyangwa idashobora kugaragara (r/r LBCL) bahawe uburyo bubiri cyangwa burenze bwo kuvura umubiri. Ibi birimo diffuse large B-cell ...Soma byinshi»

Vuba aha, umurwayi urwaye kanseri y'agahinda gakabije wari warananiwe kuvurwa inshuro nyinshi mbere yagabanutse ikibyimba nyuma yo guhabwa ubuvuzi bwa KD-496 CAR-T cell therapy, byemejwe ko azakomeza kumererwa neza nyuma y'iminsi 180 nyuma yo kuvurwa. Kuri ubu, haracyari igeragezwa ryinshi ry'ubuvuzi bushya ...Soma byinshi»

Ku ya 16 Nyakanga, ikinyamakuru mpuzamahanga cyo ku rwego rwo hejuru cyitwa Nature Medicine cyasohoye amakuru y'ubushakashatsi kuri SHR-A1904, umuti uhuza antibody-drug (ADC) wibasira claudin 18.2 (CLDN18.2), mu kuvura kanseri y'igifu iteye imbere cyangwa kanseri y'agakoko gatera uturemangingo (GC/GEJC). Abashakashatsi bakoze ubushakashatsi bwa mbere mu ...Soma byinshi»

Ku ya 17 Nyakanga 2025 – Innovent Biologics yatangaje ko Nature Medicine yashyize ahagaragara ibyavuye mu bushakashatsi bwakozwe ku cyiciro cya mbere cya IBI343, umuti urwanya CLDN18.2 ADC, mu kuvura indwara y’agakoko gatera kanseri y’igifu n’umuyoboro w’amaraso (G/GEJ). Byasohotse muri iki gikorwa mpuzamahanga gikomeye...Soma byinshi»